The United States Drug Enforcement Administration (DEA) and The United States Department of Health and Human Services (HHS) Extend Telemedicine Flexibilities through 2024

DEA received more than 38,000 comments on its proposed telemedicine rules and recently held two days of public listening sessions related to those rules.  They continue to carefully consider the input received and are working to promulgate a final set of telemedicine regulations by the fall of 2024, giving patients and medical practitioners time to plan for, and adapt to, the new rules once issued.  Accordingly, DEA, jointly with the Department of Health and Human Services (HHS), has extended current telemedicine flexibilities through December 31, 2024.  The full text of the extension, entitled “Second Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,” was submitted to the Federal Register jointly with HHS on September 29.